Home blood transfusions for cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether it is safe to give blood transfusions at home instead of in the hospital. It is for people who need regular blood transfusions for their cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You need at least 2 blood transfusions every 28 days
- You receive your cancer care at Sidney Kimmel Cancer Center (SKCCC)
- You have no history of a bad reaction to a blood transfusion
- You live within 30 miles of the Center City SKCCC location
- You must be willing to allow a nurse or staff member into your home
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers red blood cell or platelet transfusions at home for people with blood cancer who are no longer responding to treatment. It aims to improve comfort and quality of life by avoiding hospital visits.
This study compares two different strategies for when to give red blood cell transfusions to people receiving intensive chemotherapy or stem cell transplant for high-grade myeloid neoplasms, AML or B-ALL. The goal is to see which approach better improves quality of life and daily function.
This study looks at how T-cells (a type of immune cell) work in people with certain blood cancers (B-cell lymphoma or multiple myeloma) compared to healthy volunteers. The goal is to learn more about the immune system in these cancers, which may help improve future treatments.
This study collects and stores blood/tissue samples (called biospecimens) to support immunotherapy research at the cancer center. If you may qualify, your samples help researchers test new immune-based cancer treatments.
This study collects blood samples from people with cancer and healthy volunteers to help researchers understand cancer better. Your blood will be used for laboratory studies that may improve future cancer treatments.
This trial tests whether people with newly diagnosed AML can safely check their own blood counts at home and receive transfusions there while getting chemotherapy at home. If it works, you may need fewer hospital visits.
Hear when a new Hematologic Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.